PRESS RELEASE published on 05/15/2026 at 13:00, 5 months 20 days ago Sandoz confirms European Commission approval for biosimilars Bysumlog® (insulin lispro) and Dazparda® (insulin aspart), strengthening position in diabetes Sandoz Group AG confirms European Commission approval for biosimilars Bysumlog(R) (insulin lispro) and Dazparda(R) (insulin aspart), strengthening position in diabetes Diabetes Biosimilars European Commission Approval Sandoz Group AG Insulin Treatment
BRIEF published on 04/29/2026 at 07:05, 6 months 6 days ago Sandoz Reports Robust Q1 2026 Biosimilars Growth Amid Strategic Moves Strategic Partnership 2026 Guidance Biosimilars Growth Net Sales Performance Regional Analysis
BRIEF published on 04/29/2026 at 07:05, 6 months 6 days ago Sandoz annonce une forte croissance de ses biosimilaires au premier trimestre 2026 grâce à des initiatives stratégiques. Partenariat Stratégique Orientations Pour 2026 Croissance Des Biosimilaires Performance Des Ventes Nettes Analyse Régionale
PRESS RELEASE published on 04/29/2026 at 07:00, 6 months 6 days ago Sandoz reports strong biosimilars growth in Q1 2026; full-year 2026 guidance confirmed Sandoz reports strong biosimilars growth in Q1 2026 with net sales up by 3% at CC. Full-year 2026 guidance confirmed by Sandoz (SIX: SDZ/OTCQX: SDZNY) Net Sales Biosimilars Guidance Sandoz Q1 2026
BRIEF published on 04/15/2026 at 07:05, 6 months 20 days ago Sandoz and Rwanda Sign Critical Medicine Supply Agreement Healthcare Access Sandoz Agreement Rwanda Partnership Critical Medicines Antibiotics Supply
BRIEF published on 04/15/2026 at 07:05, 6 months 20 days ago Sandoz et le Rwanda signent un accord d'approvisionnement en médicaments essentiels Accès Aux Soins De Santé Accord Sandoz Partenariat Avec Le Rwanda Médicaments Essentiels Approvisionnement En Antibiotiques
PRESS RELEASE published on 04/15/2026 at 07:00, 6 months 20 days ago Sandoz signs landmark agreement with Rwandan government to ensure stable provision of critical medicines across selected African markets Sandoz signs agreement with Rwandan government to ensure stable provision of critical medicines in Africa. Strategic partnership for antibiotic and cancer therapies. Sandoz aims to provide affordable, high-quality medicines in the region Africa Sandoz Antibiotics Critical Medicines Rwandan Government
BRIEF published on 04/13/2026 at 07:05, 6 months 22 days ago 20 Years of Biosimilar Medicines: Sandoz Celebrates a Milestone Biosimilars Healthcare Savings Patient Access Omnitrope Patent Expiries
BRIEF published on 04/13/2026 at 07:05, 6 months 22 days ago 20 ans de médicaments biosimilaires : Sandoz célèbre une étape importante Biosimilaires Accès Des Patients Omnitrope Économies En Soins De Santé Expiration Des Brevets
PRESS RELEASE published on 04/13/2026 at 07:00, 6 months 22 days ago Twenty years of biosimilar medicines: a milestone that continues to transform patient access worldwide Sandoz celebrates 20 years of biosimilar medicines with over USD 1.9 billion in savings for European healthcare systems. Biosimilars transform patient access worldwide Sandoz Biologic Therapies Patient Access Biosimilar Medicines European Healthcare Savings
Published on 11/05/2026 at 08:00, 1 hour 26 minutes ago Caledonia Mining Corporation Plc: Caledonia Group Signs US$150 Million Interim Financing Facilities Agreement to Support Construction of the Bilboes Gold Project
Published on 11/04/2026 at 23:10, 10 hours 16 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 10 hours 26 minutes ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 11 hours 11 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/05/2026 at 09:15, 11 minutes ago The Platform Group: Profitable growth and reduced leverage in the first nine months of 2026, guidance confirmed
Published on 11/05/2026 at 09:05, 20 minutes ago SINBON Links Executive Pay to ESG, Cuts Scope 1 and 2 Emissions 27.68% in 2025 Sustainability Report
Published on 11/05/2026 at 09:03, 22 minutes ago u-blox sets a new size benchmark for antenna-integrated GNSS with the SAM-M11N
Published on 11/05/2026 at 09:02, 23 minutes ago RHÖN-KLINIKUM AG reports results for the third quarter of 2026
Published on 11/05/2026 at 09:00, 25 minutes ago Original-Research: ZEAL Network SE (von NuWays AG): BUY
Published on 11/05/2026 at 07:00, 2 hours 26 minutes ago Accélération confirmée au troisième trimestre 2026 Tous les métiers en croissance, chiffre d’affaires en progression de +6,5 %
Published on 11/05/2026 at 07:00, 2 hours 26 minutes ago Eurazeo’s European asset management platform continues to gain momentum, driven by sustained international fundraising
Published on 11/05/2026 at 07:00, 2 hours 26 minutes ago Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%